-
21.
公开(公告)号:US20240416124A1
公开(公告)日:2024-12-19
申请号:US18820820
申请日:2024-08-30
Applicant: SPR THERAPEUTICS, INC.
Inventor: Joseph W. Boggs, II
IPC: A61N1/36
Abstract: It has been discovered that pain felt in a given region of the body can be treated, not by motor point stimulation of muscle in the local region where pain is felt, but by stimulating muscle spaced from a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt. Spinal nerves such as the intercostal nerves or nerves passing through a nerve plexus, which comprise trunks that divide by divisions and/or cords into branches, comprise “nerves of passage.”
-
22.
公开(公告)号:US12076561B2
公开(公告)日:2024-09-03
申请号:US17727883
申请日:2022-04-25
Applicant: SPR THERAPEUTICS, INC.
Inventor: Joseph W. Boggs, II
IPC: A61N1/36
CPC classification number: A61N1/36071 , A61N1/36017
Abstract: It has been discovered that pain felt in a given region of the body can be treated, not by motor point stimulation of muscle in the local region where pain is felt, but by stimulating muscle spaced from a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt. Spinal nerves such as the intercostal nerves or nerves passing through a nerve plexus, which comprise trunks that divide by divisions and/or cords into branches, comprise “nerves of passage.”
-
23.
公开(公告)号:US20240285936A1
公开(公告)日:2024-08-29
申请号:US18623297
申请日:2024-04-01
Applicant: SPR Therapeutics, Inc.
Inventor: Maria E. Bennett , Joseph W. Boggs , John Chae
CPC classification number: A61N1/0502 , A61N1/025 , A61N1/0504 , A61N1/0551 , A61N1/36071 , A61N1/0456
Abstract: Systems and methods are provided for treating chronic pain occurring secondarily to subacromial impingement syndrome in a human body. A system is provided to deliver percutaneous electrical stimulation through at least one electrode to neurological motor points of the posterior and middle deltoid muscles to mediate such pain. One-time, continued and/or periodic dosing of treatment methods according to the present invention may result in a change to central nervous system maladaptive neuroplasticity.
-
公开(公告)号:US20230411038A1
公开(公告)日:2023-12-21
申请号:US18226309
申请日:2023-07-26
Applicant: SPR THERAPEUTICS, INC.
Inventor: Matthew deBock , Joseph Boggs, III , Nathan Crosby , Brandon Swan , Devin Sell , Bryce Dimit
CPC classification number: H01B7/0009 , H01B7/048 , A61N1/0558
Abstract: A lead may comprise a multiple filar wire comprising an inner core, an inner layer and an outer layer, where a portion of the inner layer is wound in a first orientation and the inner layer comprises a first number of filars of wire and where a portion of the outer layer is wound in a second orientation opposite the first orientation and the outer layer comprises a second number of filars of wire, the second number of filars of wire being greater than the first number of filars of wire. The lead may also comprise insulation covering a portion of the multiple filar wire, the portion of the multiple filar wire and the insulation comprising a helical coil structure wound in the first orientation and an anchor formed by the inner core, inner layer and outer layer extending away from the portion of the multiple filar wire, wherein the anchor comprises no helical coil structure.
-
公开(公告)号:US20230248975A1
公开(公告)日:2023-08-10
申请号:US18125898
申请日:2023-03-24
Applicant: SPR Therapeutics, Inc.
Inventor: Maria E. Bennett , Joseph W. Boggs , Warren M. Grill , John Chae
IPC: A61N1/36
CPC classification number: A61N1/36071 , A61N1/36021 , A61N1/36003 , A61N1/36017 , A61N1/36057
Abstract: Embodiments of the present invention provide systems and methods for the treatment of pain through activation of select neural fibers. The neural fibers may comprise one or more afferent neural fibers and/or one or more efferent neural fibers. If afferent fibers are stimulated, alone or in combination with efferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate afferent pathways in a manner approximating natural afferent activity. The afferent fibers may be associated with primary receptors of muscle spindles, golgi tendon organs, secondary receptors of muscle spindles, joint receptors, touch receptors, and other types of mechanoreceptors and/or proprioceptors. If efferent fibers are stimulated, alone or in combination with afferent fibers, a therapeutically effective amount of electrical stimulation is applied to activate intrafusal and/or extrafusal muscle fibers, which results in an indirect activation of afferent fibers associated therewith.
-
公开(公告)号:US20230146724A1
公开(公告)日:2023-05-11
申请号:US17911153
申请日:2021-03-15
Applicant: SPR THERAPEUTICS, INC.
Inventor: Matthew G. DEBOCK , Joseph W. BOGGS, II , Matthew J. WUNZIN , Bradley A. LEWIS , Devin SELL , David YOUNGBERG , Mark R. STULTZ , Joe D'ALBERO , Christopher T. LEFEVERE , Brian MULLINS , Peter MEINZ , Dave PRINCE , Russel CLUFF , Bill HARSTIG , Kristin MURRAY
CPC classification number: A61N1/3752 , A61N1/05 , A61N1/0558
Abstract: A lead connector system for use with electrical nerve stimulators is described herein. An example lead connector for an electrical stimulator system includes a body, a blade, and an insert. The body includes a cable interface and defines lead ports. The blade is affixed to the body. The blade has at least one angled portion. The insert slidably connects to the body. The insert includes a handle and a chassis. The chassis defines a lead channel coaxial with the lead ports and blade channels transverse the lead channel to accept the blade. The angled portion of the blade provides electrical contact between the cable interface and a lead inserted into the lead channel and extending through at least one of the lead ports.
-
27.
公开(公告)号:US11311727B2
公开(公告)日:2022-04-26
申请号:US16881442
申请日:2020-05-22
Applicant: SPR THERAPEUTICS, INC.
Inventor: Joseph W. Boggs, II
IPC: A61N1/36
Abstract: It has been discovered that pain felt in a given region of the body can be treated, not by motor point stimulation of muscle in the local region where pain is felt, but by stimulating muscle spaced from a “nerve of passage” in a region that is superior (i.e., cranial or upstream toward the spinal column) to the region where pain is felt. Spinal nerves such as the intercostal nerves or nerves passing through a nerve plexus, which comprise trunks that divide by divisions and/or cords into branches, comprise “nerves of passage.”
-
公开(公告)号:USD945250S1
公开(公告)日:2022-03-08
申请号:US29651470
申请日:2018-08-16
Applicant: SPR Therapeutics, Inc.
-
29.
公开(公告)号:US20220016421A1
公开(公告)日:2022-01-20
申请号:US17400187
申请日:2021-08-12
Applicant: SPR Therapeutics, Inc.
Inventor: Joseph W. Boggs, II , Nathan D. Crosby , Amorn Wongsarnpigoon
Abstract: Paind felt in a given region of the body can be treated by stimulating a peripheral nerve at a therapeutically effective distance from the region where pain is felt to generate a comfortable sensation (i.e., paresthesia) overlapping the regions of pain. Systems and methods to reduce pain in a painful region following surgical amputation of an extremity or limb may include stimulating a peripheral nerve innervating the painful region with an electrode inserted into tissue and spaced from the peripheral nerve. This method may be used to help alleviate postoperative pain in patients following amputation of an extremity or limb.
-
公开(公告)号:US11135437B2
公开(公告)日:2021-10-05
申请号:US15665909
申请日:2017-08-01
Applicant: SPR THERAPEUTICS, INC.
Inventor: Joseph W. Boggs , Amorn Wongsarnpigoon , Matthew G. deBock , Meredith J. McGee , Devin Sell , Robert B. Strother
Abstract: An introducing device for locating a tissue region and deploying an electrode is shown and described. The introducing device may include an outer sheath. An inner sheath may be disposed within the outer sheath. The inner sheath may be configured to engage an implantable electrode. In an example, the inner sheath may comprise a stimulation probe having an uninsulated portion at or near a distal end of the delivery sheath. The outer sheath may be coupled to a power source or stimulation signal generating circuitry at a proximal end. A clinician may control application of the stimulation signal to a tissue region via the outer sheath.
-
-
-
-
-
-
-
-
-